Funding for Liverpool City Region’s Life Science investment zone is to be doubled to £160 mln (€185 mln) and its benefits extended from five to 10 years, under revised plans under discussion by the city's Combined Authority.
Funding for Liverpool City Region’s Life Science investment zone is to be doubled to £160 mln (€185 mln) and its benefits extended from five to 10 years, under revised plans under discussion by the city's Combined Authority.
As Ares completed a €325 mln French logistics acquisition from Blackstone, another French portfolio came onto the market.